Fig. 2.
Platelet recovery.
Cumulative incidence of platelet recovery in recipients of unrelated donor UCB versus HLA-matched BM who received GVHD prophylaxis with MTX (BM-MTX) and UCB versus HLA-matched BM who received GVHD prophylaxis with TCD (BM-TCD). UCB versus BM-MTX: engraftment rate,P = .12; engraftment at day 45, P > .80. UCB versus BM-TCD: engraftment rate, P = .74; engraftment at day 45, P > .80.